Vanda Pharmaceuticals Announces FDA Rare Pediatric Disease Designation for Investigational Therapy for Charcot-Marie-Tooth Disease Type 2S

No financial news content was provided (HTTP 404 page not found). There is no extractable information on companies, macro conditions, or markets to assess impact or sentiment.

Analysis

No financial news content was provided (HTTP 404 page not found). There is no extractable information on companies, macro conditions, or markets to assess impact or sentiment.